Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes

scientific article published on 01 August 2007

Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.179.4.2082
P698PubMed publication ID17675466

P50authorGeorge EisenbarthQ13855780
F. Susan WongQ63411298
P2093author name stringKeiko Fukushima
Katsumi Eguchi
Hongbo Zhou
Masakazu Kobayashi
Takeshi Arakawa
Hironori Yamasaki
Norio Abiru
Dongmei Miao
Edwin Liu
Eiji Kawasaki
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectcholeraQ12090
P304page(s)2082-2088
P577publication date2007-08-01
P1433published inJournal of ImmunologyQ3521441
P1476titleAltered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes
P478volume179

Reverse relations

cites work (P2860)
Q35155875AB toxins: a paradigm switch from deadly to desirable
Q37163535Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes
Q59754901Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
Q40561404Antibodies to post-translationally modified insulin in type 1 diabetes
Q33750667Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes
Q57166646Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
Q36913132Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth
Q36499414Insulin as an autoantigen in NOD/human diabetes
Q36640081Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells
Q37638227Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice
Q36673061Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis
Q34023585Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma
Q34629092Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.
Q37758077The anti-insulin trimolecular complex in type 1 diabetes.
Q34355286Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection

Search more.